Department of Neurological Surgery

Support

Are you a patient?

OPPORTUNITIES TO SUPPORT

The Department of Neurological Surgery has been a leading center for neurological surgery for nearly 100 years. While much of our work is supported through federal grants and institutional funding, our pioneering surgical techniques, highly competitive training programs and excellence in comprehensive patient care require philanthropic support to continue to thrive.

Give Now

Please contact:

Brian Loew
Executive Director of Development
Phone: (213) 308-4764
Email: Brian.Loew@med.usc.edu

How You Can Help

Giving to the Department of Neurological Surgery helps advance the development of important surgical innovations provides talented faculty members with the funding needed to support groundbreaking research and helps translate that research into clinical applications. Our priorities include:

  • Seed funding for our early-career faculty and talented staff researchers supports basic and translational research, laying a foundation for improved understanding and treatment of disorders of the brain and spine. With philanthropic support, we hope to expand our clinical neuroscience partnerships at USC and with other institutions to bring new developments more quickly from the bench to the bedside.

  • With National Institutes of Health funding shrinking, we require philanthropic support more than ever to fund our ongoing clinical research infrastructure. With support for research personnel and data managers, our department can break new ground in surgical care of patients with brain and spine cancers and disorders, bringing the latest tools and techniques to the patients who need them.

  • Benefiting the Research of Dr. Gabriel Zada at the Keck School of Medicine of USC

    Meningiomas are the most common primary intracranial tumors, and arise from the meninges, or membrane encasing the brain. Although the causes are not well understood (most are random, but a minority run in families), these tumors account for 1 in 3 primary brain tumors diagnosed today.

    Because most meningiomas are not cancerous, research funding from major institutions such as the National Institute of Health (NIH) and the National Cancer Institute (NCI) is very limited for this tumor type. However, the symptoms and disease progression can often have debilitating effects on patients’ quality of life and their chances of survival. Furthermore, the invasive nature of these tumors often makes them incurable, and tumor recurrence and progression can lead to weakness, paralysis, blindness, coma and even death. Learn More